Micro Labs Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance Analyst collects, assesses, and reports adverse events and other safety information for medicines, both from clinical trials and post-marketing sources. The day-to-day work involves case intake, data entry into safety databases, coding with MedDRA, writing narratives, and submitting expedited reports to regulators within strict timelines. In a company like Micro Labs, you would support marketed products and ensure compliance with Indian and global pharmacovigilance regulations.

Role and Technical Knowledge

1. 1

   What is the difference between an adverse event and an adverse drug reaction?

   An adverse event is any untoward medical occurrence after exposure to a drug, which may not be causally related. An adverse drug reaction is a response to a drug that is noxious and unintended and occurs at normal doses, implying a causal relationship.

2. 2

   What are the four minimum criteria for a valid ICSR?

   An identifiable patient, an identifiable reporter, a suspect product, and an adverse event. Without all four, the case is not valid for regulatory reporting.

3. 3

   What is the difference between serious and non-serious adverse events?

   Serious events result in death, are life-threatening, require hospitalisation or prolong existing hospitalisation, cause persistent disability, are congenital anomalies, or are medically important. Non-serious events do not meet these criteria.

4. 4

   What is MedDRA and why is it used in pharmacovigilance?

   MedDRA is the Medical Dictionary for Regulatory Activities, a standardised terminology for coding adverse events. It allows consistent classification and retrieval of safety data across global regulatory submissions.

Practical Scenarios and Case Handling

1. 5

   You receive a call from a patient reporting a rash after taking a company product. What steps do you take?

   Collect all four minimum criteria, document the details in a case intake form, assess seriousness, and enter the case into the safety database. Then perform triage, coding, narrative writing, and determine reporting timelines.

2. 6

   How would you handle a case where the reporter cannot confirm the patient's age or initials?

   Document the information as unknown but still consider the case valid if other identifiers like age group or gender are available. Follow up with the reporter to obtain missing details and update the case accordingly.

3. 7

   What do you do if you notice a duplicate case in the safety database?

   Flag the duplicate, link the cases as per standard operating procedures, and merge them if appropriate. Ensure no safety information is lost and update the narrative to reflect the combined data.

4. 8

   A case of a serious adverse event is received on a Friday evening. How do you prioritise?

   Serious cases have expedited reporting timelines, often 15 calendar days for initial reports. You would start processing immediately, ensure the case is entered, and notify the responsible person so the clock is not missed.

Regulatory and Compliance Awareness

1. 9

   What are the reporting timelines for serious and non-serious cases under Indian pharmacovigilance regulations?

   Serious unexpected adverse drug reactions must be reported to CDSCO within 15 calendar days. Non-serious cases are usually reported in periodic safety update reports as per schedule.

2. 10

   What is a Periodic Safety Update Report (PSUR) and why is it important?

   A PSUR is a comprehensive report of a drug's safety profile at defined intervals. It helps regulators assess the benefit-risk balance and decide if label changes or other actions are needed.

3. 11

   What is the role of the Pharmacovigilance Programme of India (PvPI)?

   PvPI collects and analyses adverse event reports from healthcare professionals and patients across India. It supports signal detection and regulatory decisions to ensure medicine safety.

4. 12

   What is signal detection in pharmacovigilance?

   Signal detection is the process of reviewing safety data to identify new or changed adverse events that may be causally related to a drug. It can lead to further evaluation, label updates, or risk minimisation measures.

Behavioural and HR Questions

1. 13

   Why do you want to work in pharmacovigilance?

   Show genuine interest in patient safety, attention to detail, and the growing importance of drug safety monitoring. Mention that you want to contribute to ensuring medicines are safe for patients.

2. 14

   How do you handle repetitive data entry work while maintaining accuracy?

   Emphasise your ability to stay focused, follow checklists, and double-check entries. Give an example of how you maintained accuracy in a previous task, such as during an internship or project.

3. 15

   Describe a time you had to meet a tight deadline. How did you manage?

   Use the STAR method to explain the situation, task, action, and result. Highlight prioritisation, time management, and communication with team members to complete the task on time.

4. 16

   How would you handle a situation where you disagree with a senior's assessment of a case?

   Show respect and professionalism. Explain that you would present your reasoning with evidence, refer to standard operating procedures or guidelines, and escalate through the proper channel if needed.